secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zoetis Inc. (ZTS)
CIK:        0001555280
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001555280-26-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zoetis Q4 2025 revenue $2.4B (+3%), EPS $1.37; FY26 guidance $9.825-10.025B
---------------------------------------------------------------------------

- Q4 2025 revenue $2.4B (+3% reported, +4% organic); net income $603M (EPS $1.37, +6%).
- Full year 2025 revenue $9.5B (+2% reported, +6% organic); adjusted EPS $6.41 (+8% reported).
- FY 2026 guidance: revenue $9.825-10.025B (organic growth 3-5%); adjusted EPS $7.00-7.10.
- U.S. segment revenue flat organically; International up 7% organic driven by parasiticide and livestock growth.
- Acquired VPG in UK/Ireland; received approvals for long-acting OA pain mAbs Lenivia (dog) and Portela (cat) in Canada/EU.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555280/000155528026000008/0001555280-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555280/000155528026000008/zts-20260212.htm
  HTML page:      https://secwatch.observer/filing/0001555280-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer